Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 20 | $34,770,451 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 Oct 2023 16:30 | BEAM | Beam Therapeutics Inc | BELLON CHRISTINE | Chief Legal Officer | 02 Oct 2023 | Sale | 388 | 22.85 | 8,866 | D |
01 Nov 2023 16:30 | BEAM | Beam Therapeutics Inc | SIMON AMY | Chief Medical Officer | 30 Oct 2023 | Sale | 3,448 | 18.7 | 64,478 | D |
22 Nov 2023 16:05 | BEAM | Beam Therapeutics Inc | BELLON CHRISTINE | Chief Legal Officer | 20 Nov 2023 | Sale | 5,000 | 31 | 155,000 | D |
22 Nov 2023 16:05 | BEAM | Beam Therapeutics Inc | BELLON CHRISTINE | Chief Legal Officer | 20 Nov 2023 | Sale | 5,000 | 30 | 150,000 | D |
05 Jan 2024 16:30 | BEAM | Beam Therapeutics Inc | BELLON CHRISTINE | Chief Legal Officer | 03 Jan 2024 | Sale | 1,907 | 26.42 | 50,383 | D |
02 Feb 2024 16:05 | BEAM | Beam Therapeutics Inc | EVANS JOHN M. | CEO | 31 Jan 2024 | Sale | 60,000 | 25.33 | 1,519,800 | D |
15 Feb 2024 14:34 | BEAM | Beam Therapeutics Inc | FMR LLC | See Remark 1 | 14 Feb 2024 | Sale | 45,677 | 31.34 | 1,431,517 | I |
15 Feb 2024 14:34 | BEAM | Beam Therapeutics Inc | FMR LLC | See Remark 1 | 14 Feb 2024 | Sale | 854,323 | 30.51 | 26,065,395 | I |
15 Feb 2024 14:34 | BEAM | Beam Therapeutics Inc | FMR LLC | See Remark 1 | 13 Feb 2024 | Sale | 1,155 | 30.93 | 35,724 | I |
15 Feb 2024 14:34 | BEAM | Beam Therapeutics Inc | FMR LLC | See Remark 1 | 13 Feb 2024 | Sale | 410 | 30.28 | 12,415 | I |
01 Apr 2024 16:10 | BEAM | Beam Therapeutics Inc | EVANS JOHN M. | CEO | 28 Mar 2024 | Sale | 60,000 | 33.8567 | 2,031,402 | D |
03 Apr 2024 19:33 | BEAM | Beam Therapeutics Inc | CIARAMELLA GIUSEPPE | President | 01 Apr 2024 | Sale | 4,534 | 32.12 | 145,632 | D |
03 Apr 2024 19:36 | BEAM | Beam Therapeutics Inc | EVANS JOHN M. | CEO | 01 Apr 2024 | Sale | 18,102 | 32.13 | 581,617 | D |
03 Apr 2024 19:39 | BEAM | Beam Therapeutics Inc | BURRELL TERRY-ANN | Chief Financial Officer | 01 Apr 2024 | Sale | 5,446 | 32.12 | 174,926 | D |
03 Apr 2024 19:40 | BEAM | Beam Therapeutics Inc | BELLON CHRISTINE | Chief Legal Officer | 01 Apr 2024 | Sale | 3,401 | 32.12 | 109,240 | D |
03 Apr 2024 19:43 | BEAM | Beam Therapeutics Inc | SIMON AMY | Chief Medical Officer | 02 Apr 2024 | Sale | 16,530 | 30.5415 | 504,851 | D |
03 Apr 2024 19:43 | BEAM | Beam Therapeutics Inc | SIMON AMY | Chief Medical Officer | 01 Apr 2024 | Sale | 7,157 | 32.13 | 229,954 | D |
28 Jun 2024 16:15 | BEAM | Beam Therapeutics Inc | EVANS JOHN M. | CEO | 27 Jun 2024 | Sale | 60,000 | 24.5026 | 1,470,156 | D |
03 Jul 2024 16:05 | BEAM | Beam Therapeutics Inc | SIMON AMY | Chief Medical Officer | 02 Jul 2024 | Sale | 748 | 22.95 | 17,167 | D |
03 Jul 2024 16:05 | BEAM | Beam Therapeutics Inc | SIMON AMY | Chief Medical Officer | 01 Jul 2024 | Sale | 502 | 23.76 | 11,928 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)